Skip to main content
. 2015 Sep 1;10(9):e0136642. doi: 10.1371/journal.pone.0136642

Fig 3. Model selection and parameterization results for five FMDV serotypes.

Fig 3

Best-fit model results using the catalytic model (for SAT2, SAT3, and type A) or reverse catalytic mode (for SAT1 and type O) with values for the duration of immunity and serotype-specific time-varying forces of infection estimated from serology data.